The stock of Shattuck Labs Inc (STTK) has seen a -16.66% decrease in the past week, with a -18.29% drop in the past month, and a -15.27% decrease in the past quarter. The volatility ratio for the week is 11.94%, and the volatility levels for the past 30 days are at 9.13% for STTK. The simple moving average for the last 20 days is -16.03% for STTK’s stock, with a simple moving average of -34.99% for the last 200 days.
Is It Worth Investing in Shattuck Labs Inc (NASDAQ: STTK) Right Now?
The 36-month beta value for STTK is at 1.63. Analysts have varying views on the stock, with 2 analysts rating it as a “buy”, 0 rating it as “overweight”, 3 as “hold”, and 0 as “sell”.
The public float for STTK is 40.85M, and currently, shorts hold a 3.84% of that float. The average trading volume for STTK on July 04, 2025 was 269.14K shares.
STTK stock’s latest price update
Shattuck Labs Inc (NASDAQ: STTK)’s stock price has dropped by -1.61% in relation to previous closing price of $0.85. Nevertheless, the company has seen a loss of -16.66% in its stock price over the last five trading days. globenewswire.com reported 2025-07-02 that AUSTIN, TX and DURHAM, NC, July 02, 2025 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-related diseases, today announced that company management will participate in a DR3/TL1A focused panel discussion and participate in one-on-one meetings at the Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8–9, 2025 in Boston, MA. Conference Details Format: Panel Discussion and one-on-one meetings Session Title: TL1A: Pioneering a New MOA in IBD and Beyond Moderators: Thomas J.
Analysts’ Opinion of STTK
Many brokerage firms have already submitted their reports for STTK stocks, with Leerink Partners repeating the rating for STTK by listing it as a “Outperform”. The predicted price for STTK in the upcoming period, according to Leerink Partners is $4 based on the research report published on March 17, 2025 of the current year 2025.
STTK Trading at -15.56% from the 50-Day Moving Average
After a stumble in the market that brought STTK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -83.30% of loss for the given period.
Volatility was left at 9.13%, however, over the last 30 days, the volatility rate increased by 11.94%, as shares sank -28.16% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -6.68% lower at present.
During the last 5 trading sessions, STTK fell by -16.66%, which changed the moving average for the period of 200-days by -78.13% in comparison to the 20-day moving average, which settled at $0.9925. In addition, Shattuck Labs Inc saw -79.11% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at STTK starting from Redmile Group, LLC, who purchase 133,371 shares at the price of $1.25 back on Dec 04 ’24. After this action, Redmile Group, LLC now owns 5,539,724 shares of Shattuck Labs Inc, valued at $166,714 using the latest closing price.
Redmile Group, LLC, the Director of Shattuck Labs Inc, sale 133,371 shares at $1.25 during a trade that took place back on Dec 04 ’24, which means that Redmile Group, LLC is holding 5,406,353 shares at $166,714 based on the most recent closing price.
Stock Fundamentals for STTK
Current profitability levels for the company are sitting at:
- -3.92% for the present operating margin
- -0.01% for the gross margin
The net margin for Shattuck Labs Inc stands at -3.7%. The total capital return value is set at -1.07%. Equity return is now at value -71.90%, with -63.18% for asset returns.
Based on Shattuck Labs Inc (STTK), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -24.88.
Currently, EBITDA for the company is -76.74 million with net debt to EBITDA at 0.82. When we switch over and look at the enterprise to sales, we see a ratio of -0.98. The liquidity ratio also appears to be rather interesting for investors as it stands at 9.08.
Conclusion
In conclusion, Shattuck Labs Inc (STTK) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
